Skip to content

Spectral Optical Coherence Tomographer REVO2 80

by OPTOPOL Technology Sp. z o.o. Poland EUDAMED

Ref REF 224-80Model REVO 60, REVO 80, REVO nx, REVO nx 130, REVO2 60, REVO2 80, REVO2 nx 130 EMDN Z12120121

Regulatory status

as of 25 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR Number590329314119REVOTA Basic UDI-DIDate12 Dec 2024RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

European Union — CE/MDR Active

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 24 Oct 2026

Device Name
Spectral Optical Coherence Tomographer
Model / Reference
REVO 60, REVO 80, REVO nx, REVO nx 130, REVO2 60, REVO2 80, REVO2 nx 130, REF 224-80
Primary DI / UDI-DI
05903293141076
Basic UDI-DI
590329314119REVOTA
Direct Marketing DI
05903293141076
EMDN Code
Z12120121 Optical consistency tomographs
Device Class
Class IIa
Market of Registration
Poland

Manufacturer details

EUDAMED SRN
PL-MF-000004770

Other devices from Optopol Technology Sp Z O O

See all devices from Optopol Technology Sp Z O O →

Properties & raw data

Show properties, registry sources and raw records
  • Measuring Function
Other properties (12)
  • Sterile: No
  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Incorporates Medicinal Product: No

Sources (1)

  • EUDAMED 05903293141076|590329314119REVOTA 61 fields · synced 24 Oct 2026